Important Safety Alert regarding Coeur, Inc. disposable 125 mL syringe used in Optivantage™ DH Contrast Media Injector
Click here to view Mallinckrodt Coeur syringe alert.
Mallinckrodt's Methylphenidate Hydrochloride Extended-Release Tablets, USP
Click here for full prescribing information.
Mallinckrodt’s Position on Safe and Effective Use of Opioids
Click here for Mallinckrodt’s Position on Safe and Effective Use of Opioids
Voluntary recall issued for Coiled Tubing
Click here for the Coiled Tubing Recall Letter 2-10-12
Voluntary recall issued for Disposable Magnetic Resonance Syringes/Tubing
Click here for the Disposable MR Tubing and Syringes Recall Letter 2-10-12
Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information
03/25/2013 8:47 AM
Mallinckrodt Launches Additional Dosage Strengths of Generic CONCERTA® in U.S.
02/13/2013 3:05 AM
Mallinckrodt Medical BV will promote and distribute Rapiscan® (regadenoson) in France, Italy, Belgium, and Spain
05/20/2013 9:19 AM
Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims
05/20/2013 9:18 AM
Covidien Announces Pricing of $750 Million Senior Notes Offering
This information is intended for the use of our customers, patients and healthcare professionals in the United States only. Covidien recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The prescribing information included here may not be appropriate for use outside the United States.